Percutaneous Neurostimulation in Knee Osteoarthritis
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Tanta University
- Trial code
- NCT07637682
- Record updated
- 18 June 2026
- Original description
Peripheral nerve stimulation (PNS) is a drug-free pain management procedure that uses electrical impulses to target specific nerves and block pain signals. PNS helps decrease perception of pain, providing real answers to patients dealing with chronic knee pain. The case study discussed in this presentation is of the use of PNS targeting the superior lateral genicular nerve and the saphenous nerve for a patient with moderate to severe knee pain from osteoarthritisRead full original descriptionShow less
Percutaneous Peripheral Temporary Neurostimulation in Moderate to Severe Knee Osteoarthritis
Peripheral nerve stimulation (PNS) is a drug-free pain management procedure that uses electrical impulses to target specific nerves and block pain signals. PNS helps decrease perception of pain, providing real answers to patients dealing with chronic knee pain. The case study discussed in this presentation is of the use of PNS targeting the superior lateral genicular nerve and the saphenous nerve for a patient with moderate to severe knee pain from osteoarthritis
Inclusion: adults between the ages of 30 and 70 years with a clinical diagnosis of moderate to severe knee OA who suffered knee pain; Patients who cannot afford intra-articular injections or radiofrequency ablation (RFA); patients who had failed 2 different oral pain medications and 6 weeks of physical therapy.
Exclusion: patients evaluated by an orthopaedic surgeon and deemed to be surgical candidates due to knee pathologies other than OA; patients on anticoagulation therapy, who were not permitted to stop anticoagulation; patients with previous trauma, neurological or endocrine diseases like diabetes mellitus, and knee tumors; and patients with inflammatory arthritis; people who had received an intra-articular knee injection within the last 6 months; Patients with OA show improvement in pain after physiotherapy; pregnant patients; Patients with tendon tears, bursitis, or calcified tendonitis as proven by imaging.